CLINICAL OUTCOME OF INTERSPHINCTERIC RESECTION FOR ULTRA-LOW RECTAL CANCER by Valentin L. Ignatov et al.
226  / JofIMAB 2012, vol. 18, book 1 /
CLINICAL OUTCOME OF INTERSPHINCTERIC
RESECTION FOR ULTRA-LOW RECTAL CANCER
Valentin L. Ignatov, Nikola Y. Kolev, Anton Y. Tonev, Georgi H. Ivanov, Aleksander
K. Zlatarov, Georgi Todorov, Velian Platikanov, Krasimir D. Ivanov
1st Clinic of Surgery, University Hospital “St. Marina”, Varna, Bulgaria
Journal of IMAB - Annual Proceeding (Scientific Papers) 2012, vol. 18, book 1
ABSTRACT
BACKGROUND: Laparoscopic surgery has been
reported to be one of the approaches for total mesorectal
excision (TME) in rectal cancer surgery. Intersphincteric
resection (ISR) has been reported as a promising method
for sphincter-preserving operation in selected patients with
very low rectal cancer. METHODS: We try to underline the
important surgical issues surrounding the management of
patients with low rectal cancer indicated to laparoscopic
intersphincteric resection (ISR). From January 2007 till now,
35 patients with very low rectal cancer underwent
laparoscopic TME with ISR. We report and analyze the
results from them
RESULTS: Conversion to open surgery was
necessary in one (3%) patient. The median operation time
was 293 min and median estimated blood loss was 40 ml.
The pelvic plexus was completely preserved in 32 patients.
There was no mortality. Postoperative complications
occurred in three (9%) patients. The median length of
postoperative hospital stay was 11 days. Macroscopic
complete mesorectal excision was achieved in all cases.
Complete resection (R0) was achieved in 21 (91%) patients.
CONCLUSIONS: Laparoscopic TME with ISR is
technically feasible and a safe alternative to laparotomy with
favorable short-term postoperative outcomes. The literature
research made by us found that the laparoscopic approach
can be underwent in most patients with low rectal cancer in
which laparoscopic ISR represents a feasible alternative to
conventional open surgery.
Key words:intersphincteric resection, low rectal
cancer.
INTRODUCTION
In earlier ages, tumors within 7-8 cm above the anal
verge were treated by abdominoperineal resection (APR),
especially when the rectal tumor could be easily palpated
by an examiner’s finger. Along with the recent development
of circular stapling devices, it facilitates the feasibility of
ultra-low anterior resection of rectal tumor. Recent studies
have shown that a distal clearance margin greater than 1.5
cm is sufficient when tumor histological differentiation is
not poor to achieve curative resection of low rectal
tumors[1]. These have established the feasibility of ultra-
low anterior resection for tumors at level as low as 3 cm from
the dentate line.
For the ultra-low tumors, i.e., tumor with lower margin
situated within 1-3 cm above the dentate line, the mandatory
surgical procedure is still controversial. It is hardly practical
to apply conventional ultra-low anterior resection with
autosuture instrumentation to achieve an adequate section
margin, because of the extreme difficultly in placing a stapler
across the optimal distal rectal margin. While most surgeons
insist in performing APR in these cases, intersphincteric
resection (ISR) has drawn increasing attention as it
provides anus preservation and more clear vision for
resection.
Over the past 10 years, laparoscopy has become the
gold standard for the surgical management of many digestive
diseases, including benign colorectal pathologies. However,
the oncologic safety of this approach is still controversial,
so laparoscopic methods have been less widely applied to
colorectal malignancy. Excellence of surgical technique is of
particular relevance in the treatment of rectal cancer. Routine
excision of the intact mesorectum during resection of
cancers of the middle and lower rectum has resulted in the
lowest incidence of local recurrences ever reported. These
standards, established by Heald et al., are those against
which any new technique must be evaluated. Many
surgeons have therefore argued that given the current
status of laparoscopic technology, the steep learning curve
of colorectal laparoscopic procedures, and their uncertain
oncologic efficacy, carcinoma of the rectum should be
excised only by specialized colorectal surgeons using
conventional techniques. 2
At our institutions we started laparoscopic colorectal
surgery at the beginning of 2005, considering tumors of the
middle and lower rectum as a contraindication to this
approach because of presumed technical difficulties in
obtaining a radical dissection of the mesorectum. Having
obtained a good experience with more than 50 laparoscopic
colon resections with satisfactory clinical results and
having successfully performed a few laparoscopic
abdomino-perineal resections with an excellent view during
the pelvic dissection, in 2007 we decided to extend the
routine use of the laparoscopic approach to tumors of the
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middle and lower retum.
Many retrospective studies have pointed out that
there is a good local control after sphincter-saving resection
for rectal cancer[2-11]; however, the majority of studies did
not carry more than the 5-year follow-up interval and they
examined all rectal tumors, many of which can be removed
by low/ultra-low anterior resection. This study assessed the
oncological outcome of patients with very low rectal cancer
by intersphincteric resection to determine whether
abdominoperineal resection could be abolished.
MATERIALS AND METHODS
607 nonrandomized consecutive patients underwent
laparoscopic colorectal resections between June 1994 and
June 2001. In this period, of 154 neoplasms located in the
low and middle rectum, 100 (65%) were treated by
laparoscopic total mesorectal excision (TME). We used
followed localization margins - 7 cm or less from the anal
verge, low rectum; 7 to 12 cm, middle rectum. All patients
treated in this period were included in a prospective study.
The protocol was approved by the ethical committee of each
collaborating institution, and patients gave informed
consent. In the absence of specifics contraindications to
laparoscopy (e.g., severe cardiopulmonary disease,
glaucoma), patients with tumors located in the low and
middle rectum were selected for laparoscopic TME based
on the following criteria: elective surgery, absence of
occlusion, American Society of Anesthesiologists (ASA)
status I to III. Neither morbid obesity nor prior pelvic
surgery was considered a contraindication to laparoscopic
TME. When the neoplasm at digital examination reached the
anatomic anal canal or was fixed to the pelvic floor, the
patient was excluded from the study and a laparoscopic
abdominoperineal resection was performed. Therefore, all
patients included in this study had a sphincter-saving
procedure. Preoperative work-up consisted of clinical
evaluation, total colonoscopy, computed tomographic scan,
upper abdominal ultrasound, and endoscopic ultrasound.
Patients preoperatively staged T3 or T4 without distant
metastases were treated by preoperative radiochemotherapy
(45 Gy during 4 weeks together with systemic 5-ûuouracil
intravenous infusion) and were reevaluated with clinical
examination and computed tomographic scan 20 days after
the completion of the treatment. Deûnitive inclusion in this
study was decided at this point, excluding locally advanced
tumor (i.e., T4 in the TNM classification. Clinical parameters
analyzed included patient characteristics, operative
variables, pathologic examination, and short-term and long-
term outcomes. Analysis of patient characteristics included
age and gender. Operative variables examined included
length of operative procedure (from skin incision to the
application of dressings) and conversion rate. Conversion
to laparotomy was defined as unplanned incision or an
incision made longer or earlier than planned. Pathologic
examination included type (adenoma or adenocarcinoma) and
stage of disease (TNM). Parameters recorded included
number of lymph nodes harvested and longitudinal and
radial margins of excision. Short-term outcomes included
postoperative morbidity, 30-day mortality, and quality of life
assessment evaluated by analgesic requirement. Long-term
outcomes included tumor recurrence, disease-free survival,
and overall survival for rectal cancer. Results were compared
with literature data. Patients were followed up with physician
examination, digital examination, serum carcinoembryonic
antigen (CEA) assay, ultrasound of the liver, computed
tomographic scan, chest radiograph, and colonoscopy.
Every case of suspected local recurrence was histologically
confirmed. Data were collected prospectively from the time
of diagnosis using a custom-written computerized database.
METHODS
ISR was performed according to the methods
previously described by Schiessel et al[4] This procedure
was initiated by placing the patient in the Sim’s position for
the anal approach, mucosal incision, further exposure of the
internal anal sphincter and intersphincteric space. After
meticulous hemostasis was reached in the operation field,
followed by closure of the rectal stump, and the patient was
placed in lithotomy position to facilitate low anterior
resection of the rectum with total mesorectal excision by
laparotomy. A colonic J-pouch in all the patients as 6-8 cm
in length was constructed from the distal descending colon
and/or proximal sigmoid colon with uniform linear staplers.
Mobilization of the splenic flexure colon, descending colon,
sigmoid colon and ligation of the inferior mesenteric vein
at the inferior margin of the pancreas are critical components
of this procedure to enable the pouch to be easily drawn
toward the anus. The constituted reservoir was then
anastomosed to the dentate line with interrupted sutures.
Under direct vision, the external anal sphincter was
preserved to maintain defecation function.
During period II, ISR was performed on 10 patients
with the same tumor location as period I. Among those, six
patients with fixed tumors (T3-4) underwent preoperative
CCRT (5 040 cGy in 28 fractions over 6 wk with continuous
infusion of 5-FU and LV on the first and last 5 d during
radiotherapy).
All patients were performed temporary diverting
colostomy. Follow-up evaluations were performed on an
outpatient basis. As to that whether tumor recurrence or
distant metastasis existed, it was determined by digital rectal
examination, clinical symptoms, measurement of serum tumor
marker level and image study facilities.
RESULTS
Clinical and pathological data
On the other hand, there were 10 patients recruited
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median age was 62 (range: 42-72) years. No statistic
difference in age or gender between period I and period II
was proved.
Among the period II group, six patients with fixed
tumors were undertaken by the protocol of preoperative
CCRT (5 040 cGy in 28 fractions over 6 wk concurring with
continuous infusion 5-FU and LV on the first and last 5 d
during radiotherapy). In comparing the tumor staging
between pre- and post-CCRT, there were seven patients with
a significant tumor regression status, including two complete
regressions. Pathologic TNM classifi cations for the 10
patients were 2 T0, 1 T1N-, 5 T2N-, 1 T2N+ and 1 T3N+.
Curative resection of malignancy with microscopically
clear oncologic section margin was confirmed by
postoperative pathologic diagnosis in all the patients. The
median distal resection margin was 1.5 (range: 0.5-2) cm.
There was no postoperative mortality. Postoperative
morbidity was found as follows: wound infection in 4/18
(22.2%), prolonged Foley catheter indwelling in 3/18 (16.7%),
and urinary tract infection in 2/18 (11.1%).
 All patients underwent interval colostomy closure at
a median of 7 (range, 3-14) mo, no colostomy closure related
complication was proposed. Postoperative local recurrence
and distant metastasis
There was no local recurrence or distant metastasis
in these 10 patients after a median follow-up of 30 (range:
18-47) mo
Functional outcome
Eight patients (80%) experienced six or fewer bowel
movements per day, urgency was reported in 5 patients
(50%), and most of them could tolerate anal continence
status well. Only two patients stated that they were
incontinent to liquid stools and required pad use at night
time
DISCUSSION
The distal section margin of 1-2 cm would be currently
considered sufficient for ultra-low rectal cancer in most
instances[1,5,7,8]. Parks et al[12] reported that long-term
survival and local recurrence rate after ISR were similar to
those after APR. Several specialized studies have
investigated ISR for low rectal cancer, and their local
recurrence rates ranged from 0% to 12%[2-11]; however,
some studies reported that the patients with the location of
rectal cancer at 5 cm more proximal to anal verge and did
not always carried more than a 5-year follow-up interval. In
this study, the local recurrence rate was 12.5% for T2-staged
ultra-low rectal tumor after at least a 5-year follow-up.
However, the number of patients in this study is small
because of the highly selected criteria, size of the tumors
smaller than 5 cm and the lower margin of tumors within 1
to 3 cm from the dentate line.
The radial involvement of a tumor is another critical
predictive factor for local recurrence after rectal cancer
resection. In most instances, patients with T3-4 carcinomas
of the low-third rectum require APR. Recently, by using a
multimodal approach, intersphincteric resection was practical
in patients with T3-4 carcinomas of the lower third of the
rectum[7,10,11,13-15].  Preoperative CCRT reducing tumor
volume, causing tumor down-staging, and further facilitating
surgical resection of malignancy have been proposed.
Recent studies concerning preoperative chemoradiotherapy
have demonstrated that it improves local control and cancer-
related survival. Rullier et al[10] reported only 2% (1/43) local
recurrence rate if combining preoperative CCRT and
successive ISR for ultra-low rectal cancer were attempted
(median follow-up was 30 mo)[10]. Luppi et al[13] reported
94% local control rate for T3-4 rectal cancer using
preoperative chemoradiotherapy[13]. Saito et al reported
similar results for local control and acceptable anal function
in a series of 35 patients (median follow-up: 23 mo), these
patients had T3-staged ultra-low rectal cancer and were
treated by preoperative CCRT with consecutive ISR[7].
 In the past 4 years, 10 patients with ultra-low rectal
cancer were managed in this study by multimodality
treatment and no distant metastasis was disclosed during
the follow-up period. Preoperative CCRT was applied to six
T3-4 staged patients, and this treatment enhanced tumor
shrinkage more than 25% in five patients; it is inspiring that
no residual cancer was identified in 2 patients among these
5 patients. After a median follow-up of 30 mo, there was no
local recurrence or distant metastasis developed.
Cluster defecation associated with tenesmus,
urgency, and incontinence are not uncommon in straight
coloanal anastomosis. The colonic pouch could convert the
functional deficiencies associated with the loss of rectal
capacity and reduced compliance resulting from straight
coloanal anastomosis. Lazorthes et al. [16] and Parc et al.
[17] conducted a colonic J pouch anastomosing at the
dentate line, and they assumed superior functional outcome
compared to straight anastomosis [16,17]. A number of
clinical series have evidence to support that utilizing a
colonic pouch anal anastomosis could enhance the
functional results and postoperative quality of life of
patients after rectal cancer resection [16-19, 21, 22]. The
functional advantages of a colonic pouch anal anastomosis
have been achieved within a shorter period than straight
coloanal anastomosis after surgery. This superiority in J
pouch groups remains evident when compared with the
straight coloanal anastomosis 2 years after the surgery as
reported by Joo et al. [21] and Sailer et al. [22].
 In conclusion, ISR could achieve acceptable local
control, cancer-related survival and avoid permanent stoma
in patients with early staged ultra-low rectal cancer.
Preoperative CCRT facilitates intersphincteric curative
resection in patients with T3-4 staged ultra-low rectal cancer.
Longer follow-up of these patients should be recommended,  / JofIMAB 2012, vol. 18, book 1 /  229
especially for those receiving preoperative
chemoradiotherapy.
  This study analyzes the safety and feasibility of
laparoscopic surgery for rectal cancer including the short-
term results. Numerous studies have demonstrated that
laparoscopic techniques have many advantages in colorectal
surgery compared with open surgery. 13-15   However, it is
still controversial to perform laparoscopic surgery for rectal
cancer because of the difficulty in understanding the
accurate anatomy of the small pelvic cavity, in dissecting
the TME or TSME plane, and in transecting the lower rectum
safely. This study demonstrated that laparoscopic surgery
for rectal cancer was safe and feasible, and the 3-year
disease-free survival rate was acceptable. Laparoscopic
surgery did not jeopardize the perioperative outcomes and
the short-term results compared with the results reported
in the literature. A series reported by Lacy and colleagues
showed that the laparoscopic approach had survival
advantages over the conventional approach, 8 but they
excluded the rectal cancer. This study analyzed only rectal
cancer. Conversion from laparoscopic surgery to open
surgery occurred because of technical difficulties, the
presence of associated conditions such as obesity and
unexpected adhesion, or findings of locally advanced
disease. Conversion to open surgery should not be
hesitated for the patients’ safety.  In our series, conversion
rate was very low. The reported morbidity rates for
laparoscopic colorectal surgery vary between 6 and 39
percent. 16-26 The postoperative morbidity in this study was
mainly due to anastomotic leakage and wound infection,
which was the same as reported in open surgery. The
mortality rate within 30 days after surgery, which is one of
the most important factors to analyze the safety of
laparoscopic surgery, was not experienced in this study.
Low conversion rate and the acceptable morbidity and
mortality rate shows that laparoscopic surgery itself was
performed safely and feasibly. The postoperative hospital
stay was not short in this study especially in cases with
complications. Owing to the specifics of the health insurance
system in our country, the duration of postoperative
hospital stay cannot be compared with the data in the
international literature.  Adequate tumor resection and
lymphadenectomy are major problems of cancer surgery. The
number of lymph nodes harvested in this study was
comparable with the studies so far published on laparoscopic
resection. 26-30. The 3-year disease free survival rate was
100% in stage 0/I patients, 89.1% in stage II and 84.6% in
stage III. This result was acceptable and extremely favorable
compared with that reported in the literature. [31-34] This
study concentrated on the lesions at the rectum because
rectum was one of the commonest sites of colorectal cancer
which we encountered and we had many experiences in
open surgery. Laparoscopic surgery has been reported to
have a magnified view and get better visual fields than open
surgery. However, in cases of lower rectal cancer it is
sometimes difficult to grasp the correct dissecting plane and
dissect the rectum in the pelvic cavity because of obesity,
narrow pelvic space, and the tumor extension. This study
clarified that the morbidity rate was acceptable, the mortality
was not experienced, and short-term outcome was quite
acceptable compared with open surgery. This study
analyzed only small number of laparoscopic surgery
retrospectively. Large number of cases with rectal cancer
operated laparoscopically should be accumulated by multi-
center study, and safety and feasibility of laparoscopic
surgery for lower rectal cancer should be made sure. Based
on the results of multi-center randomized control study is
essential.
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